Cryoport
- Market cap
- 878.76M
- P/E (TTM)i
- -19.28
- P/Bi
- 1.98
- EPSi
- 1.40
- Div yieldi
- 0.00%
- 52W posi
- 91%
Anonymous reader poll. Unscientific, not investment advice.
About Cryoport
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
- Founded
- 1990
- CEO
- Mr. Jerrell W. Shelton
- Employees
- 738
- Headquarters
- Brentwood, Tennessee, United States of America
- Fiscal year end
- 12-31
- Website
- cryoportinc.com
Company profile
- Exchange
- US
- Symbol
- CYRX
- Market-cap rank
- #3336
- Listing date
- 2015-04-23
- Market cap
- 878.76M
- Float cap
- 797.20M
- Shares out
- 50.65M
- Float shares
- 45.95M
Sectors & themes
Quote time 2026-10-08 09:16:57 · For reference only, not investment advice and not tailored to your situation.